Summit Therapeutics Q1 EPS $(0.06) Up From $(1.43) YoY; Exits Q1 With Cash & Equivalents Worth $157M
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.